Sign in

CIK 0001817241 · <br>Emerging growth company

Artiva Biotherapeutics, Inc.

Sign in to watch
Ticker
ARTV
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863614316
Phone
(858) 267-4467
Business address
5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,341,159
in 16 filings, $529K under 10b5-1 plans

Net −$2,341,159. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Aslan Fred −$1.8M Chief Executive Officer sold 14% of stake
  2. Horan Christopher −$230K Chief Tech Operations Officer sold 9% of stake
  3. Bush Jennifer −$186K COO, CLO, Compliance Officer sold 7% of stake
  4. Banerjee Subhashis −$128K Chief Medical Officer sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2026-11-02 Horan Christopher Chief Tech Operations Officer Sale −10,423 $4.18 $44K 302,321
2026-11-02 Bush Jennifer COO, CLO, Compliance Officer Sale −8,439 $4.18 $35K 357,720
2026-11-02 Banerjee Subhashis Chief Medical Officer Sale −1,110 $4.18 $5K 168,738
2026-11-02 Aslan Fred Chief Executive Officer Sale −62,178 $4.18 $260K 1,457,428
2026-10-06 Aslan Fred Chief Executive Officer Sale 10b5-1 −23,463 $7.20 $169K 1,519,606
2026-10-05 Horan Christopher Chief Tech Operations Officer Sale −10,340 $6.84 $71K 312,744
2026-10-05 Bush Jennifer COO, CLO, Compliance Officer Sale −8,370 $6.84 $57K 366,159
2026-10-05 Banerjee Subhashis Chief Medical Officer Sale −1,099 $6.84 $8K 169,848
2026-10-05 Aslan Fred Chief Executive Officer Sale −61,696 $6.84 $422K 1,543,069
2026-09-15 Aslan Fred Chief Executive Officer Grant or award +110,000 1,604,765
2026-09-15 Aslan Fred Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +315,000 315,000
2026-09-10 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Director Stock Option (Right to Buy) +16,250 16,250
2026-09-10 Aslan Fred Chief Executive Officer Grant or award +45,000 1,494,765
2026-09-10 Aslan Fred Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +155,000 155,000
2026-09-10 Stoppel Laura Director Grant or award · Director Stock Option (Right to Buy) +16,250 16,250
2026-09-10 Sorg Elaine K. Director Grant or award · Director Stock Option (Right to Buy) +16,250 16,250
2026-09-10 HOUGEN ELIZABETH L Director Grant or award · Director Stock Option (Right to Buy) +16,250 16,250
2026-09-10 DANIELS BRIAN Director Grant or award · Director Stock Option (Right to Buy) +16,250 16,250
2026-09-10 Baker Daniel G. Director Grant or award · Director Stock Option (Right to Buy) +16,250 16,250
2026-09-10 MOORE ALISON Director Grant or award · Director Stock Option (Right to Buy) +16,250 16,250

Page 1 of 11 · 203 trades